Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis.
Bassi, Nicola, Amital, Daniela, Amital, Howard et al. · The Israel Medical Association journal : IMAJ · 2008
Quick Summary
This review examines multiple biological abnormalities that might explain ME/CFS symptoms. Researchers found evidence that the immune system may not work properly in ME/CFS patients, with potential problems in natural killer cells, antibody levels, and inflammatory markers. The study also suggests that certain autoantibodies and problems with chemical messengers in the nervous system might contribute to fatigue, brain fog, and muscle pain.
Why It Matters
Understanding potential biological mechanisms of ME/CFS is crucial for developing diagnostic tests and targeted treatments. This synthesis of immune and neurological abnormalities helps validate that ME/CFS has objective biological basis rather than being purely psychological, which remains important for patient recognition and clinical research direction.
Observed Findings
Decreased natural killer cell and macrophage activity reported in ME/CFS patients
Immunoglobulin G subclass deficiencies (IgG1, IgG3) and reduced serum complement components
Presence of autoantibodies including anti-serotonin, anti-microtubule-associated protein 2, and anti-muscarinic cholinergic receptor 1
Evidence of excessive oxidative stress following physical exertion
Impairment in vasoactive neuropeptide metabolism
Inferred Conclusions
ME/CFS likely involves multiple overlapping biological mechanisms rather than a single cause
Immune dysregulation appears to be a significant component of disease pathogenesis
Autoimmune-like phenomena with autoantibodies may contribute to neurological symptoms
Metabolic and neurochemical abnormalities may underlie cognitive and pain symptoms
Remaining Questions
Which of these abnormalities are primary drivers versus secondary consequences of illness?
How do these different mechanisms interact, and which patients have which abnormalities?
What This Study Does Not Prove
This review does not establish causation—identifying abnormalities does not prove they cause ME/CFS symptoms. It does not determine whether abnormalities are primary disease drivers or secondary effects of chronic illness and reduced activity. The 2008 publication date means more recent mechanistic research is not included, and findings require replication in controlled studies.